Compare ZDAI & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZDAI | PMI |
|---|---|---|
| Founded | 2022 | 1981 |
| Country | Hong Kong | United States |
| Employees | 33 | 75 |
| Industry | General Bldg Contractors - Nonresidential Bldgs | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 14.1M |
| IPO Year | N/A | N/A |
| Metric | ZDAI | PMI |
|---|---|---|
| Price | $2.91 | $0.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 87.7K | ★ 34.9M |
| Earning Date | 05-15-2026 | 06-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.11 |
| 52 Week High | $11.48 | $13.68 |
| Indicator | ZDAI | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 42.47 |
| Support Level | $0.30 | $0.11 |
| Resistance Level | $4.10 | $0.27 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | 0.15 | 0.05 |
| Stochastic Oscillator | 74.14 | 48.92 |
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.